Page last updated: 2024-11-06

diazodiphenylmethane

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

diphenyldiazomethane: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID61230
SCHEMBL ID81262
MeSH IDM0458304

Synonyms (28)

Synonym
methane, diazodiphenyl-
1,1'-(diazomethylene)dibenzene
benzene, 1,1'-(diazomethylene)bis-
diazonio(diphenyl)methanide
methane,diazo,diphenyl
diphenyldiazomethane
[diazo(phenyl)methyl]benzene
diazodiphenylmethane
FT-0657861
A842545
883-40-9
unii-vg5twb4mms
vg5twb4mms ,
diazodiphenylmethane [forbidden]
AKOS015900560
SCHEMBL81262
(diazomethylene)dibenzene
diphenyidiazomethane
dipheyldiazomethane
diazo(diphenyl)methane
diphenyl diazomethane
1,1-diphenyldiazomethane
DTXSID80236941
D97767
AS-75709
CS-0141885
(diazo(phenyl)methyl)benzene
1,1'-(diazomethylene)bis(benzene)
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 17.81

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index17.81 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.42 (4.65)
Search Engine Demand Index10.37 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (17.81)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]